Home

This course will teach you everything you need to know to be a successful Data Protection Officer as required by the GDPR. The course takes place over four days (one day per week) and involves lectures, discussion and practical exercises. This is followed by a written assessment on day 5. Candidates are then required to complete a project (in their own time) to achieve the certificate.

Conference Series LLC organizing splendorous Pharmaceutical conferences welcomes you to attend the 8th Global Pharmacovigilance & Drug Safety Summit to be held during July 6-8, 2017 in Kuala Lumpur, Malaysia focuses on the advancements in pharmacovigilance and risk management. It is a 3-day event offering the Exhibition, at venue to showcase the new and emerging technologies and have wider sessions involving Keynote presentation, Oral, YRF ( student presentation), poster, e-poster presentations and exhibition.
Global Pharmacovigilance Market is expected to reach USD 5.51 billion by 2020, according to a new study by Grand View Research, Inc. Increasing incidence rates of adverse drug reaction and the introduction of stringent drug safety regulations are some key drivers of this market. ADR is responsible for approximately 5% of the hospitalization in developed countries annually, and this is expected to boost usage rates over the next six years. Pharmacovigilance has witnessed a significant rise in usage rates in the recent times owing to growing global geriatric population triggering a growth in demand for new drug development.

The field of Pharmacovigilance is growing by and large, its development is making high impact in field of Pharmaceuticals and medical sciences. 8th Global Pharmacovigilance & Drug Safety Summit focusses on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence..The main theme of 8th Global Pharmacovigilance & Drug Safety Summit is “Innovations in Pharmacovigilance for Systematic Safety and Management”.

Sessions Include talks on Drug Safety, Adverse Drug Reactions, Pharmacokinetics and Pharmacodynamics, Pre-Clinical and Clinical Trials, Challenges in Pharmacovigilance, Clinical Trials on Various Disorders, Pharmacovigilance Market, Clinical Research and Statistics, Case Report in Clinical Trials, Pharmacovigilance Significance & Scope, Continental Pharmacovigilance, Good Pharmacovigilance Practice, Pharmacovigilance and Risk Management, Medical devices Pharmacovigilance, Veterinary Pharmacovigilance, Biopharmaceutics, PV Data Base Management, PV Consultings And Bussiness opportunity, Regulatory Affairs, Growth strategies in Pharma, Pharmacy Practices and its Challenges

Meet at the experts gathering to Join Global Scientific influencers from , Asia, Middleeast , USA (America), Europe at Pharmacoepidemiology and Clinical Research conferences happening from July 06-08, 2017, Kuala Lumpur, Malaysia. Pharm-epidemiology Congress July 06-08, 2017 at Kaula Lumpur, Malaysia is organised aiming to bring together leading academic professors, scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Pharmacoepidemiology and Clinical research. It also provides a premier interdisciplinary pavement for Pharma, Biotech and Medical Device industries and to represent their company and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmacoepidemiology, Clinical trials and clinical research.

The AI Now Symposium is designed to address the biggest challenges we face as AI moves further into our everyday lives. Leaders from industry, academia, civil society, and government will share ideas for technical design, research and policy directions.

This event is free and open to the public; it will also be live streamed on our website. Learn more about our program and speaker line-up below. (Go to event website for program)

Please join us at the upcoming Washington, DC KnowledgeNet Chapter meeting and learn about the Federal Government’s Controlled Unclassified Information program. This event will provide an overview of the program’s inception and implementation, and have a discussion about its accompanying National Institute of Standards and Technology (NIST) security requirements for nonfederal entities that handle Federal CUI, which includes government contractors, non-profit organizations, and academic/research institutions.

Speakers:

• Kelley Dempsey, Senior Information Security Specialist, NIST IT Laboratory’s Computer Security Division, National Institute of Standards and Technology, and co-author of NIST Special Publication 800-171
• Mark Riddle, Senior Program Analyst, CUI Oversight and Implementation Lead, National Archives and Records Administration, and co-author of NIST Special Publication 800-171

Moderator:

• Koosh Orandi, Federal Confidential Information Program Lead, US Office of Confidentiality and Privacy, Deloitte Consulting

Thank you to our meeting host, Deloitte LLP, for providing snacks and beverages.

Registration is REQUIRED. Space is limited.